Related Experiment Video

Updated: Aug 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

[Antihypertensive drug utilization in obese patients]

Peter Bramlage1, Carsten Bramlage, Wilhelm Kirch

  • 1Institut für Klinische Pharmakologie, Technische Universität Dresden, Dresden. peter.bramlage@mailbox.tu-dresden.de

Medizinische Klinik (Munich, Germany : 1983)
|February 3, 2006
PubMed

Insights

Obese patients with hypertension often receive combination drug therapy, with ACE inhibitors and diuretics most frequently prescribed. However, current treatment strategies may not adequately control blood pressure, necessitating optimized combination regimens.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Context:

  • Obesity and arterial hypertension are prevalent, often co-occurring conditions.
  • Effective blood pressure management in obese hypertensive patients remains a challenge.
  • Limited recent data exist on antihypertensive prescribing patterns in primary care for this population.

Purpose:

  • To analyze antihypertensive drug prescription patterns in obese patients with arterial hypertension.
  • To identify preferred drug classes, commonly used substances, and dosing strategies.
  • To evaluate the adequacy of current pharmacotherapy for blood pressure control in this demographic.

Summary:

  • A nationwide observational study analyzed data from over 70,000 hypertensive patients.
  • Antihypertensive pharmacotherapy for obese patients showed variation in drug selection but less in dosage.
  • Drug combinations, particularly ACE inhibitors and diuretics, were commonly used.

Impact:

  • Current antihypertensive drug availability and prescription practices may be insufficient for adequate blood pressure control in obese patients.
  • Optimized combination therapy, including reduced doses of certain agents and high doses of RAS inhibitors, could enhance efficacy and reduce side effects.
  • Findings highlight the need for improved treatment strategies for managing hypertension in the obese population.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...